Clinical trial
IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis
NCT02175134 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis
- Lead sponsor
- Asan Medical Center
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2014
- Completion date
- June 30, 2018
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
suspected tuberculous peritonitis